Improvement in lower-extremity peripheral arterial disease by nocturnal hemodialysis
- PMID: 12500241
- DOI: 10.1053/ajkd.2003.50010
Improvement in lower-extremity peripheral arterial disease by nocturnal hemodialysis
Abstract
A 42-year-old man with end-stage renal disease (ESRD) was referred for conversion to nocturnal hemodialysis (NHD) therapy from conventional hemodialysis (CHD) therapy because of refractory intermittent claudication secondary to peripheral arterial disease (PAD). The patient was initiated on CHD therapy in 1976 and subsequently had undergone two unsuccessful renal transplantations. While on CHD therapy, his clinical course was complicated by worsening vascular and soft-tissue calcification. Extensive dystrophic soft-tissue calcification was noted bilaterally in his hands, lower extremities, and sacral region, requiring surgical excision. Lower-extremity arterial Doppler scans documented vascular calcification and a pronounced decrease in peripheral arterial flow bilaterally. After conversion to NHD therapy (7.5 h/session five times weekly), the patient became symptom free and had significant clinical improvements in (1) hemodynamics, measured by clinic blood pressure and two-dimensional echocardiography, (2) biochemical profile, and (3) a sustained improvement in arterial Doppler flow measured by duplex Doppler ultrasound. We conclude that NHD was able to improve lower-extremity PAD in our patient. Further observational and interventional studies are required to investigate the therapeutic potential of NHD for the treatment of PAD in patients with ESRD.
Copyright 2003 by the National Kidney Foundation, Inc.
Similar articles
-
Successful pregnancy with nocturnal hemodialysis.Am J Kidney Dis. 2004 Nov;44(5):912-6. Am J Kidney Dis. 2004. PMID: 15492959
-
Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).Int Angiol. 2006 Sep;25(3):287-92. Int Angiol. 2006. PMID: 16878078 Clinical Trial.
-
Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis.Am J Kidney Dis. 2003 Feb;41(2):403-10. doi: 10.1053/ajkd.2003.50066. Am J Kidney Dis. 2003. PMID: 12552503
-
Management of peripheral arterial disease in chronic kidney disease.Cardiol Clin. 2005 Aug;23(3):225-36. doi: 10.1016/j.ccl.2005.03.006. Cardiol Clin. 2005. PMID: 16084274 Review.
-
Peripheral artery disease: therapeutic advances.Expert Rev Cardiovasc Ther. 2008 Apr;6(4):539-53. doi: 10.1586/14779072.6.4.539. Expert Rev Cardiovasc Ther. 2008. PMID: 18402543 Review.
Cited by
-
Cardiac and vascular structure and function parameters do not improve with alternate nightly home hemodialysis: an interventional cohort study.BMC Nephrol. 2011 Oct 3;12:51. doi: 10.1186/1471-2369-12-51. BMC Nephrol. 2011. PMID: 21962236 Free PMC article. Clinical Trial.
-
Nocturnal hemodialysis is associated with restoration of early-outgrowth endothelial progenitor-like cell function.Clin J Am Soc Nephrol. 2011 Jun;6(6):1345-53. doi: 10.2215/CJN.10911210. Epub 2011 May 19. Clin J Am Soc Nephrol. 2011. PMID: 21597025 Free PMC article.
-
Home haemodialysis and uraemic toxin removal: does a happy marriage exist?Nat Rev Nephrol. 2012 Oct;8(10):579-88. doi: 10.1038/nrneph.2012.189. Epub 2012 Aug 28. Nat Rev Nephrol. 2012. PMID: 22926247 Review.
-
The effects of nocturnal hemodialysis compared to conventional hemodialysis on change in left ventricular mass: rationale and study design of a randomized controlled pilot study.BMC Nephrol. 2006 Feb 22;7:2. doi: 10.1186/1471-2369-7-2. BMC Nephrol. 2006. PMID: 16504054 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical